Discover two under-the-radar stocks with significant upside potential, based on recent large-scale purchases by their respective CFOs. Learn why CFOs are a reliable indicator of potential stock growth and explore the compelling investment cases for Epsilon Energy (EPSN) and Relmada Therapeutics (RLMD).